Meglumine antimonate is a pentavalent antimonial drug used for treatment of canine leishmaniasis.
Recommended dose rate in dogs is 100 mg/kg subcutaneously once a day for twenty-eight consecutive days (3.3 mL/10 kg/day).
- Miró G et al (2008) Canine leishmaniosis–new concepts and insights on an expanding zoonosis: Part two. Trends Parasitol 24:371–377
- Valladares JE et al (1997) Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs. Am J Trop Med Hyg 57(4):403-406